Susceptibility of anaerobic Gram-negative rods to trovafloxacin

Drugs

Volumn 58, Issue SUPPL. 2, 1999, Pages 193-194

  Litterio, Mirta ^a,b   Castello, L ^a   Rollet, A ^a   Di Martino, A ^a   Greco, G ^a   Fernandez Canigia L ^a   Fernandez M I ^a   Predari, S ^a   Bianchini, H ^a  

^a Asociacion Argentina Microbiologia   (Argentina)

^b HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFOXITIN; CHLORAMPHENICOL; CLINDAMYCIN; IMIPENEM; LEVOFLOXACIN; METRONIDAZOLE; SULBACTAM; TROVAFLOXACIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARGENTINA; CONFERENCE PAPER; CONTROLLED STUDY; GRAM NEGATIVE BACTERIUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

BACTERIA (MICROORGANISMS); NEGIBACTERIA;

EID: 0032707947     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-199958002-00058     Document Type: Conference Paper

References (5)

1. Citron DM, Appleman MD. Comparative in vitro activities of Trovafloxacin (CP-99,219) against 221 aerobic and 217 anaerobic bacteria isolated from patients with intra-abdominal infections. Antimicrob Agents Chemother 1997; 41: 2312-6
2. Felmingham D, Robbins MJ, Ingley K, et al. In-vitro activity of trovafloxacin, a new fluoroquinolone, against recent clinical isolates. J Antimicrob Chemother 1997; 39 Suppl. B: 43-9
3. Kenneth EA, Ashcraft D, Bowman KA. Comparative in vitro activities of trovafloxacin (CP 99,219) and other antimicrobials against clinically significant anaerobes. Antimicrob Agents Chemother 1997; 41: 484-7
4. Sumannen P, Baron EJ, Citron DM, et al. Wadsworth anaerobic bacteriology manual. 5th ed. Belmont, Ca: Star Publishing, 1993
5. National Committee for Clinical Laboratory Standards. Methods for antimicrobial susceptibility testing of anaerobic bacteria. Approved standard M11-A4. Villanova, Pa: NCCLS, 1997